For now, Bayer remains a hostage to courtroom calendars. The convergence of the settlement opt‑out outcome, the Supreme Court decision, and the underlying pharma improvements sets up a binary few ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results